Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2026-05-26 @ 10:35 AM
Study NCT ID:
NCT03209492
Status:
COMPLETED
Last Update Posted:
2019-04-11
First Post:
2017-07-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
Sponsor:
Takeda
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostate Cancer | View |
Keywords: